Merck aspires to be the premier research-intensive biopharmaceutical company. We’re at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals. Through our Impact Venture Fund, we’re able to deploy financial resources in ways that may generate not only improved access to health care for underserved populations, but also financial returns and strategic opportunities — all while growing a sustainable global health ecosystem and attracting additional capital and partners.